Toilet training in healthy children: Results of a questionnaire study involving parents who make use of day-care at least once a week

2013 ◽  
Vol 33 (3) ◽  
pp. 316-323 ◽  
Author(s):  
Nore Kaerts ◽  
Alexandra Vermandel ◽  
Guido Van Hal ◽  
Jean-Jacques Wyndaele
2008 ◽  
Vol 28 (4) ◽  
pp. 305-308 ◽  
Author(s):  
Alexandra Vermandel ◽  
Marijke Van Kampen ◽  
Stefan De Wachter ◽  
Joost Weyler ◽  
Jean-Jacques Wyndaele

2007 ◽  
Vol 49 (4) ◽  
pp. 249-255 ◽  
Author(s):  
Luz Elena Espinosa-de los Monteros ◽  
Verónica Jiménez-Rojas ◽  
Felipe Aguilar-Ituarte ◽  
Miguel Cashat-Cruz ◽  
Alfonso Reyes-López ◽  
...  

2019 ◽  
Vol 59 (1) ◽  
pp. 409-417 ◽  
Author(s):  
Irini Lazou Ahrén ◽  
Anna Berggren ◽  
Cristina Teixeira ◽  
Titti Martinsson Niskanen ◽  
Niklas Larsson

Abstract Background The combination of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 (commercially available as Probi Defendum®) has previously been reported to reduce the incidence, duration and severity of naturally acquired common colds in adults. The aim of the present study was to evaluate the impact of Probi Defendum® on aspects of common cold in healthy children 1–6 years of age attending day care. Methods A total of 131 children, out of the planned 320, were recruited into the study during 1 common cold season and randomised to consume once daily either 109 CFU (colony forming units) of the probiotic product or placebo. Due to unforeseen reasons, the recruitment of more children did not continue beyond the first cold season. Results There were 106 children that completed the study out of the 131 randomised. Daily consumption of the probiotic product for a period of 3 months significantly reduced the severity of the symptom “nasal congestion/runny nose” with a mean severity score for the whole study period of 7.5 ± 9.7 in the probiotic group and 13.9 ± 15.2 in the placebo (p < 0.05). Moreover, significantly less concomitant medication was used in the probiotic group. When the data were projected to a larger population corresponding to the originally estimated sample size, the results were in favour of the probiotic group regarding the reduced absence from day care (p < 0.05), reduced mean total severity per day in the reported episodes (p < 0.05) and reduced severity of the symptom “crying more than usual” (p < 0.05). Conclusion Intake of Probi Defendum® once daily for a period of 3 months was beneficial to children and reduced the severity of common colds.


2012 ◽  
Vol 6 (02) ◽  
pp. 176-180 ◽  
Author(s):  
Cláudia Moura ◽  
Maria Clara Duarte Fregolente ◽  
Isabel Julien Martini ◽  
Daniela Ferreira Domingos ◽  
Erivaldo José da Silva ◽  
...  

Introduction: The diarrhea associated with gastroenteritis is a major cause of morbidity and mortality worldwide, affecting mainly infants. The characterization of both viral and bacterial agents associated with gastroenteritis can establish policies for surveillance, prevention and treatment of infections. Group A rotaviruses are the major infectious agent associated with dehydration in children, followed by pathotypes of Escherichia coli. There are three main types of clinical infections caused by E. coli strains that have acquired virulence genes: (i) enteric and diarrheal diseases, (ii) urinary tract infections, and (iii) sepsis and meningitis. Methodology: In this study, the objective was to identify the presence of rotavirus and diarrhogenic E. coli in the feces of children 4 to 14 months of age who displayed no gastroenteritis symptoms and stayed all day in a day-care center. We analyzed 188 samples using PAGE and PCR to identify rotaviruses and E. coli virulence genes, respectively. Results: Thirty-six samples (19.1%) were positive for at least one pathotype of E. coli. Nineteen were identified to be of the EPEC group and fifteen of the EAEC group. Rotaviruses were not identified. Conclusions: As EPEC and EAEC are potential pathogens for children less than one year of age or immunocompromised individuals, our results show the importance of appropriate monitoring by public health agencies.  In the situation that we have studied, children can be considered asymptomatic carriers of these pathogens and can transmit them to other susceptible children.  


PEDIATRICS ◽  
1988 ◽  
Vol 82 (5) ◽  
pp. 810-811
Author(s):  
CANDICE E. JOHNSON

In Reply.— Dr Brunell's concerns are valid, and we certainly agree that protective efficacy can only be defined by prospective controlled trials, such as that of Weibel et al (N EngI J Med 1984;310:1409). However, we disagree with the concept that data about protection can only be derived from family exposure data. Arbeter et al (Pediatrics 1986;78(suppl):748-756) reviewed all studies of varicella vaccine in healthy children and combined household day-care and playmate exposures as we did.


2002 ◽  
Vol 36 (1) ◽  
pp. 63-68 ◽  
Author(s):  
Semíramis Guimarães ◽  
Maria Inês L Sogayar

OBJETIVES: To detect anti-Giardia lamblia serum antibodies in healthy children attending public day care centers and to assess serological tests as tools for estimating the prevalence of G. lamblia in endemic areas. METHODS: Three separate stool specimens and filter paper blood samples were collected from 147 children ranging from 0 to 6 years old. Each stool sample was processed using spontaneous sedimentation and zinc sulfate flotation methods. Blood samples were tested by indirect immunofluorescence (IIF) and enzyme-linked immunosorbent assay (ELISA) for Giardia IgG. RESULTS AND CONCLUSIONS: Of 147 individuals tested, 93 (63.3%) showed Giardia cysts in their feces. Using IIF and ELISA, serum antibodies were detected in 93 (63.3%) and 100 (68%) samples , respectively. Sensitivity of IIF and ELISA was 82% and 72%, respectively. However, ELISA revealed to be less specific (39%) than IIF (70%). IIF also showed a higher concordance with microscopic examination than ELISA.


Sign in / Sign up

Export Citation Format

Share Document